Director, Medical Affairs

at  Eupraxia Pharmaceuticals Inc

ABOUT US:

Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support an extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians want to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the DiffuSphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia’s DiffuSphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, also to be applicable in oncology, infectious disease and other critical disease areas.
Eupraxia’s EP-104GI is currently in a Phase 1b/2a trial, the RESOLVE trial, for the treatment of EoE. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. The trial met its primary endpoint and three of the four secondary endpoints. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company’s website at: www.eupraxiapharma.com.
We are looking for people who would like to work for a fast-paced, growing company that fosters a creative spirit and integrated teamwork and who are eligible to work in Canada or the USA.
Job Description:
The Director, Medical Affairs will be responsible for defining and implementing KOL strategies to develop and maintain positive KOL endorsement and product champions for Eupraxia in all aspects of Ep104 use, including OA, EOE and GI diseases. The role will also lead Eupraxia medical education initiatives and conference activities.
Reports to: Chief Medical Officer

Key Responsibilities:

• The role will develop and execute KOL strategies required to prepare the market for Eupraxia EP-104IAR (pre-approval) and EOE and proposed GI indications to position the product and the company as a leader in these arenas.
• A primary goal for this role will be to identify, engage and develop key opinion leaders (KOLs) in the OA/EOE/GI therapeutic areas across the US, EU and other key markets as required.
• Post approval, the focus will be to develop these relationships further.
• Working with operations management and the Clinical/Regulatory teams, the Director, Medical Affairs will

o Define the US/EU and other market KOL strategy, including activities involving KOLs at international congresses, Advisory Boards and National/Regional meetings.
o Develop KOLs and communicate the evidence base supporting EU-104IAR, EOE and GI indications.

o Once the strategy has been developed, the Director, Medical Affairs will be responsible for the implementation of these tactics, working in cooperation with the wider Clinical Team.

• This role will support developing and maintaining positive relationships and interaction with key advocacy groups as part of the pre-approval market development required for a successful launch.
• The Director, of Medical Affairs will be a pivotal interface between the Brand Management team, Program Management, Operations, Regulatory team, and Clinical colleagues to ensure a coordinated approach to interacting with KOLs, advocacy groups and other third-party groups.
• In conjunction with the responsibilities above, they will assist in developing a KOL contact management database for all Eupraxia employees (medical /regulatory/commercial). The job holder will coordinate to maintain and keep the system current.
• As necessary, the Director, Medical Affairs will contribute to :

o The development of Medical Affairs/Commercial budgets

o Be responsible for managing the approved budgets

• Other ad hoc duties and assignments as requested for the overall performance of the function and the company.

Preferred Qualifications and Expertise:

• The ideal candidate will have demonstrated expertise in Medical Affairs with KOLs and advocacy organizations. This is likely to be at least 5 years of experience gathered in either the Pharmaceutical Industry or agencies.
• A track record of identifying and developing Key Opinion Leaders (preferably within/for the US).
• Evidence of direct experience of developing and interacting with patient advocacy groups.
• The individual will have a medical or advanced health sciences degree.
• Understanding of OIG, PhRMA, & ACCME guidelines.
• Has experience in using and developing contact management databases.
• Experience in the therapeutic area of gastrointestinal, osteoarthritis or auto-immune diseases would be an advantage but is not required.
• The position requires significant travel (up to approx.40% - 50%).

Additional attributes:

• Ability to maintain a high level of confidentiality.
• Exercise excellent customer service skills.
• Excellent communication and time management skills and possess a high organizational ability.
• Attention to detail due to various factors affecting contract entitlements.
• Possess troubleshooting, problem-solving, and creative/innovative thought-processing skills.
• Understand office formats and procedures.
• Demonstrated leadership skills and ability to document and implement processes and procedures.
• Self-motivated and self-directed.

Job Type: Full-time
Pay: $190,000.00-$250,000.00 per year

Additional pay:

• Bonus pay

Benefits:

• Dental care
• Employee assistance program
• Extended health care
• Life insurance
• Vision care

Schedule:

• Monday to Friday

Application question(s):

• Are you legally authorized to work in either Canada or the United States?

Work Location: Remot

Key Responsibilities:

• The role will develop and execute KOL strategies required to prepare the market for Eupraxia EP-104IAR (pre-approval) and EOE and proposed GI indications to position the product and the company as a leader in these arenas.
• A primary goal for this role will be to identify, engage and develop key opinion leaders (KOLs) in the OA/EOE/GI therapeutic areas across the US, EU and other key markets as required.
• Post approval, the focus will be to develop these relationships further.
• Working with operations management and the Clinical/Regulatory teams, the Director, Medical Affairs wil

o Once the strategy has been developed, the Director, Medical Affairs will be responsible for the implementation of these tactics, working in cooperation with the wider Clinical Team.

• This role will support developing and maintaining positive relationships and interaction with key advocacy groups as part of the pre-approval market development required for a successful launch.
• The Director, of Medical Affairs will be a pivotal interface between the Brand Management team, Program Management, Operations, Regulatory team, and Clinical colleagues to ensure a coordinated approach to interacting with KOLs, advocacy groups and other third-party groups.
• In conjunction with the responsibilities above, they will assist in developing a KOL contact management database for all Eupraxia employees (medical /regulatory/commercial). The job holder will coordinate to maintain and keep the system current.
• As necessary, the Director, Medical Affairs will contribute to

o Be responsible for managing the approved budgets

• Other ad hoc duties and assignments as requested for the overall performance of the function and the company